Skip to main content
logo
Ryvu Therapeutics S.A. (WSE:RVU)
Poland flag Poland · Delayed Price · Currency is PLN
31.60
+0.35 (1.12%)
Jun 27, 2025, 4:45 PM CET

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Novel Small Molecule Therapies
46.86M
Log In
Log In
Log In
Log In
Upgrade
Novel Small Molecule Therapies Growth
20.32%
Log In
Log In
Log In
Log In
Upgrade
Service
-
Log In
Log In
Log In
Log In
Upgrade
Service Growth
-
Log In
Log In
Log In
Log In
Upgrade
Bioinformatics
-
Log In
Log In
Log In
Log In
Upgrade
Bioinformatics Growth
-
Log In
Log In
Log In
Log In
Upgrade
Exclusion Income between Segments
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
European Union Countries
41.66M
Log In
Log In
Log In
Log In
Upgrade
European Union Countries Growth
69.25%
Log In
Log In
Log In
Log In
Upgrade
Other Countries
5.16M
Log In
Log In
Log In
Log In
Upgrade
Other Countries Growth
-63.73%
Log In
Log In
Log In
Log In
Upgrade
Poland
38.00K
Log In
Log In
Log In
Log In
Upgrade
Poland Growth
-64.15%
Log In
Log In
Log In
Log In
Upgrade
United States
-
Log In
Log In
Log In
Log In
Upgrade